Fermented ginseng extract, BST204, disturbs adipogenesis of mesenchymal stem cells through inhibition of S6 kinase 1 signaling

• Published in: Journal of ginseng research Vol. 44; no. 1; pp. 58 - 66
• Main Authors: Yi, Sang Ah, Lee, Jieun, Park, Sun Kyu, Kim, Jeom Yong, Park, Jong Woo, Lee, Min Gyu, Nam, Ki Hong, Park, Jee Hun, Oh, Hwamok, Kim, Saetbyul, Han, Jihoon, Kim, Bo Kyung, Jo, Dong-Gyu, Han, Jeung-Whan
• Format: Journal Article
• Language: Korean
• Published: 2020
• Subjects: Wnt genes; H2BS36 phosphorylation; BST204; Adipogenesis; S6K1
• ISSN: 1226-8453; 2093-4947

Background: The biological and pharmacological effects of BST204, a fermented ginseng extract, have been reported in various disease conditions. However, its molecular action in metabolic disease remains poorly understood. In this study, we identified the antiadipogenic activity of BST204 resulting from its inhibition of the S6 kinase 1 (S6K1) signaling pathway. Methods: The inhibitory effects of BST204 on S6K1 signaling were investigated by immunoblot, nuclear fractionation, immunoprecipitation analyses. The antiadipogenic effect of BST204 was evaluated by measuring mRNA levels of adipogenic genes and by chromatin immunoprecipitation and quantitative real-time polymerase chain reaction analysis. Results: Treatment with BST204 inhibited activation and nuclear translocation of S6K1, further decreasing the interaction between S6K1 and histone H2B in 10T1/2 mesenchymal stem cells. Subsequently, phosphorylation of H2B at serine 36 (H2BS36p) by S6K1 was reduced by BST204, inducing an increase in the mRNA expression of Wnt6, Wnt10a, and Wnt10b, which disturbed adipogenic differentiation and promoted myogenic and early osteogenic gene expression. Consistently, BST204 treatment during adipogenic commitment suppressed the expression of adipogenic marker genes and lipid drop formation. Conclusion: Our results indicate that BST204 blocks adipogenesis of mesenchymal stem cells through the inhibition of S6K1-mediated histone phosphorylation. This study suggests the potential therapeutic strategy using BST204 to combat obesity and musculoskeletal diseases.